Stock info BioNTech | Filter Basic-Info
Stock: BioNTech (Germany small caps)
| Last Price | 86.40 | Max Price | 125.08 |
| Min Price | 86.34 | 1 Year return | -42.48 |
| Avg. Target | 0.00 | Expected Return | -100.00 % |
| Sector | Health Care | Subsector | Biotechnology |
| Sell | 0 | Rating | |
| Hold | 0 | Concensus | |
| Buy | 0 |
Loading...
Sector Review BioNTech
Loading...
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 109 | 141,925 | 0.08 % |
| 2020 | 482 | 170,231 | 0.28 % |
| 2021 | 18,977 | 252,886 | 7.50 % |
| 2022 | 17,311 | 238,500 | 7.26 % |
| 2023 | 0 | 0 | 0.00 % |
Advice BioNTech
| Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
|---|---|---|---|---|---|
| October 09, 2021 | Jefferies & Co. | BioNTech | Hold | 230.00 | 40.57 % |
News BioNTech
China set to approve BioNTech vaccine before July
China is on track to approve its first foreign COVID-19 vaccine -- from BioNTech (NASDAQ:BNTX) -- within the next 10 weeks, The Wall Street Journal reports.
In December, BioNTech reached an agreement with Shanghai Fosun Pharmaceutical (OTCPK:SFOSF) to supply...
Annual reports BioNTech
No Records Found
Profile BioNTech
No Records Found
Results BioNTech
| Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Revenue |
0
|
0
|
62
|
128
|
109
|
482
|
| Costs |
0
|
0
|
147
|
176
|
288
|
467
|
| Profit |
0
|
0
|
-86
|
-48
|
-179
|
15
|
| Margin of profit |
0.0
|
0.0
|
-139.04
|
-37.64
|
-164.90
|
3.15
|
| ROI |
0.0
|
0.0
|
173.73
|
-18.04
|
-36.28
|
1.11
|
Balance BioNTech
| Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|---|
| Equity |
0
|
0
|
-49
|
266
|
493
|
1,372
|
| Debt |
0
|
0
|
424
|
387
|
304
|
947
|
| Total assets |
0
|
0
|
375
|
653
|
798
|
2,319
|
| Solvency |
0.0
|
0.0
|
-13.16
|
40.76
|
61.87
|
59.17
|
| Cash |
0
|
0
|
172
|
412
|
521
|
1,347
|
| Cashflow |
0
|
0
|
-53
|
-59
|
-199
|
-13
|
| Employees |
0
|
0
|
0
|
0
|
0
|
|
| Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow / Debt |
0.0
|
0.0
|
-0.12
|
-0.15
|
-0.65
|
-0.01
|
Details BioNTech
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
0.0
|
0.0
|
0.0
|
0.0
|
33.44
|
| Eps |
0.0
|
-0.38
|
-0.21
|
-0.85
|
0.06
|
| Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
1440.00
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Stocks |
0
|
0
|
0
|
0
|
|
| Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
|
Dividend BioNTech
Price info BioNTech
|
Date
|
Price
|
|---|---|
|
18 Apr 2024
|
86.40
|
|
17 Apr 2024
|
86.34
|
|
09 Apr 2024
|
89.31
|
|
05 Apr 2024
|
89.94
|
|
03 Apr 2024
|
91.53
|
|
30 Mar 2024
|
92.25
|
|
22 Mar 2024
|
91.99
|
|
18 Mar 2024
|
92.48
|
|
15 Mar 2024
|
92.91
|
|
12 Mar 2024
|
96.30
|
|
11 Mar 2024
|
91.27
|
|
09 Mar 2024
|
91.27
|
|
07 Mar 2024
|
91.39
|
|
01 Mar 2024
|
88.96
|
|
29 Feb 2024
|
91.43
|
|
27 Feb 2024
|
93.52
|
|
22 Feb 2024
|
92.74
|
|
21 Feb 2024
|
91.24
|
|
20 Feb 2024
|
91.67
|
|
15 Feb 2024
|
91.46
|
|
14 Feb 2024
|
90.58
|
|
13 Feb 2024
|
93.86
|
|
09 Feb 2024
|
94.10
|
|
08 Feb 2024
|
95.05
|
|
07 Feb 2024
|
96.00
|
|
06 Feb 2024
|
93.35
|
|
05 Feb 2024
|
92.65
|
|
01 Feb 2024
|
95.04
|
|
31 Jan 2024
|
94.98
|
|
30 Jan 2024
|
95.78
|
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 